✦ LIBER ✦

Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide

✍ Scribed by Sirisha Nandipati; Alexis Demopoulos

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 259 KB
Volume: 105
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-011-0611-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival of patients with high grade gli

Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis

✍ Timothy F. Witham; Melanie B. Fukui; Carolyn Cidis Meltzer; Richard Burns; Dougl 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

BACKGROUND. The diagnosis of leptomeningeal dissemination of malignant glioma (meningeal gliomatosis) is associated with poor survival. Intrathecal (IT) chemotherapeutic agents used to achieve tumor control and improve survival include methotrexate, cytosine arabinoside (ara-C), thiotriethylenephosp

Relationship between ornithine decarboxy

Relationship between ornithine decarboxylase levels in anaplastic gliomas and progression-free survival in patients treated with DFMO–PCV chemotherapy

✍ Victor A. Levin; Jacob L. Jochec; Lisa M. Shantz; Kenneth D. Aldape 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB

## Abstract The purpose of this study was to assess the relationship between progression‐free survival (PFS) in patients treated with DFMO + PCV (procarbazine, CCNU, vincristine) chemotherapy for malignant gliomas with tumor cell ornithine decarboxylase (ODC) activity. Formalin‐fixed slides were ob

Incidence of early pseudo-progression in

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

✍ Walter Taal; Dieta Brandsma; Hein G. de Bruin; Jacoline E. Bromberg; Annemarie T 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract ## BACKGROUND. Radiotherapy (RT) plus concomitant and adjuvant temozolomide (TMZ) is now the standard of care for patients with newly diagnosed glioblastoma. The occurrence of pseudo‐progression directly after RT is a recognized phenomenon, but to the authors' knowledge its incidence a

Prognostic factors and survival in a pro

Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis

✍ Gregorio Catalán-Uribarrena; Gaizka Bilbao-Barandica; Iñigo Pomposo-Gaztelu; Jos 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 333 KB

Pseudoprogression in patients with malig

Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53

✍ Hyun-Cheol Kang; Chae-Yong Kim; Jung Ho Han; Ghee Young Choe; Jae Hyoung Kim; Je 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 214 KB

Prolonged survival in a patient with dis

Prolonged survival in a patient with disseminated malignant teratoma in the presence of a persistently elevated serum alpha-fetoprotein level

✍ Clive Stewart Lawson; Janine Lucia Mansi; Eve Wiltshaw 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views

The authors report a patient with disseminated malignant teratoma who has survived for 3.5 years after discontinuation of treatment despite a persistent and nonprogressive elevation of his serum alpha-fetoprotein level. Potential sources of the marker in his case are discussed and the possibility of